INMC Reports Updated Five-Year Survival Data for Neoadjuvant Melanoma Therapy
The International Neoadjuvant Melanoma Consortium has published updated five-year survival data from its pooled analysis of neoadjuvant therapy in melanoma, extending mature follow-up results.